Nadavia Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 42878537
Granledet 6, 4600 Køge
Income statement (kDKK)
2022 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | - 145.22 |
| Total depreciation | -2.48 |
| EBIT | - 147.70 |
| Other financial expenses | -0.90 |
| Pre-tax profit | - 148.60 |
| Income taxes | 31.80 |
| Net earnings | - 116.80 |
Assets (kDKK)
2022 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current other receivables | 14.79 |
| Current deferred tax assets | 31.80 |
| Short term receivables total | 46.59 |
| Balance sheet total (assets) | 46.59 |
Equity and liabilities (kDKK)
2022 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | - 116.80 |
| Shareholders equity total | -76.80 |
| Non-current liabilities total | |
| Current loans from credit institutions | 0.10 |
| Current trade creditors | 35.25 |
| Current owed to participating | 22.53 |
| Current owed to group member | 65.51 |
| Current liabilities total | 123.39 |
| Balance sheet total (liabilities) | 46.59 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.